Bayesian Capital Management, LP Collegium Pharmaceutical, Inc Transaction History
Bayesian Capital Management, LP
- $854 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
236Shares Held
39.4MCall Options Held
84.2KPut Options Held
18.6K-
Black Rock Inc. New York, NY5.79MShares$243 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$143 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$110 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$99.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$97.7 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.43B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...